Nanomedicine plays a vital role in targeting therapeutics to the desired site of action. Over
the years, several nanomedicines, like monoclonal antibodies (Rituximab, Brentuximab …

Extensive research is underway to discover a safe and effective vehicle to deliver the
vaccines at the desired cutaneous site. These efforts majorly comprise the development of a …

This research is based on three fundamental aspects of successful biosimilar development
in the challenging biopharmaceutical market. First, biosimilar regulations in eight selected …

This study aims to establish a cost basis for biologics manufacturers and policymakers by
quantifying the price and time required to bring a biosimilar from the lab to market. For …

The development of monoclonal antibodies (mAbs) in recent decades has enhanced the
therapeutic options available to clinicians for the treatment of several diseases such as …

The steep rise in the cost of brand name biologics and expiration of their patents led to the
arrival of several new biosimilars in the United States (US) and European Union (EU) …

Advancements in the identification of molecular drug targets and new therapeutic options for
different cancer types have paved the way for target-based therapies for cancer. In this vein …

The book delves into the role of biosimilars in the field of cancer treatment. It also discusses
the application of biosimilars in various cancer types, from colorectal and cervical to …

Abstract What Is Known and Objective To investigate and describe the real‐world use of
IBI305, a biosimilar of bevacizumab, across all approved indications in the first 12 months …

Dendrimers possess some outstanding characteristics, for instance, tunable chemical
compositions, consistent globular shapes, size in the nano range, promising biological …